Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease

Oghenekome Gbinigie, Emma Ogburn, Julie Allen, Jienchi Dorward, Melissa Dobson, Tracie-Ann Madden, Ly-Mee Yu, David M Lowe, Najib Rahman, Stavros Petrou, Duncan Richards, Kerenza Hood, Mahendra Patel, Benjamin R Saville, Joe Marion, Jane Holmes, May Ee Png, Gail Hayward, Mark Lown, Victoria HarrisBhautesh Jani, Nigel Hart, Saye Khoo, Heather Rutter, Jem Chalk, Joseph F Standing, Judith Breuer, Layla Lavallee, Elizabeth Hadley, Lucy Cureton, Magdalena Benysek, Monique I Andersson, Nick Francis, Nicholas P B Thomas, Philip Evans, Oliver van Hecke, Mona Koshkouei, Maria Coates, Sarah Barrett, Clare Bateman, Jennifer Davies, Ivy Raymundo-Wood, Andrew Ustianowski, Jonathan Nguyen-Van-Tam, Andrew Carson-Stevens, Richard Hobbs, Paul Little, Christopher C Butler*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Citations (Scopus)
12 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease'. Together they form a unique fingerprint.

Medicine and Dentistry